Username
Oncology
Early Phase / Multiple Disease Site
Hematologic Malignancies
Early Phase Team
Plasma Cell Disorders
Multiple Myeloma
Relapsed/Refractory
3 or more prior lines
menu
Search
Should appear
Must not appear
Categories
Search
Protocols
show categories
Search
ICHNOS-ISB-1442-101
Phase I/II
OPEN TO ACCRUAL
A Phase 1/2, First-in-Human, Multicenter, Open-Label, Dose-Escalation and Dose-Expansion Study of Single-Agent ISB 1442 in Patients with Relapsed/Refractory Multiple Myeloma
Search